Your browser doesn't support javascript.
loading
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.
Goff, Peter H; Riolobos, Laura; LaFleur, Bonnie J; Spraker, Matthew B; Seo, Y David; Smythe, Kimberly S; Campbell, Jean S; Pierce, Robert H; Zhang, Yuzheng; He, Qianchuan; Kim, Edward Y; Schaub, Stephanie K; Kane, Gabrielle M; Mantilla, Jose G; Chen, Eleanor Y; Ricciotti, Robert; Thompson, Matthew J; Cranmer, Lee D; Wagner, Michael J; Loggers, Elizabeth T; Jones, Robin L; Murphy, Erin; Blumenschein, Wendy M; McClanahan, Terrill K; Earls, Jon; Flanagan, Kevin C; LaFranzo, Natalie A; Kim, Teresa S; Pollack, Seth M.
Afiliación
  • Goff PH; Department of Radiation Oncology, University of Washington Medicine, Seattle, Washington.
  • Riolobos L; Department of Medicine, University of Washington Medicine, Seattle, Washington.
  • LaFleur BJ; Department of Cancer Vaccine Institute, University of Washington Medicine, Seattle, Washington.
  • Spraker MB; University of Arizona BIO5 Institute, Tucson, Arizona.
  • Seo YD; Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
  • Smythe KS; Department of Surgery, University of Washington Medicine, Seattle, Washington.
  • Campbell JS; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Pierce RH; Sensei Biotherapeutics, Inc., Boston, Massachusetts.
  • Zhang Y; Sensei Biotherapeutics, Inc., Boston, Massachusetts.
  • He Q; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Kim EY; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Schaub SK; Department of Radiation Oncology, University of Washington Medicine, Seattle, Washington.
  • Kane GM; Department of Radiation Oncology, University of Washington Medicine, Seattle, Washington.
  • Mantilla JG; Department of Radiation Oncology, University of Washington Medicine, Seattle, Washington.
  • Chen EY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
  • Ricciotti R; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
  • Thompson MJ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
  • Cranmer LD; Department of Orthopedics and Sports Medicine, University of Washington, Seattle, Washington.
  • Wagner MJ; Seattle Cancer Care Alliance, Seattle, Washington.
  • Loggers ET; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Jones RL; Seattle Cancer Care Alliance, Seattle, Washington.
  • Murphy E; Department of Medical Oncology, University of Washington Medicine, Seattle, Washington.
  • Blumenschein WM; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • McClanahan TK; Seattle Cancer Care Alliance, Seattle, Washington.
  • Earls J; Department of Medical Oncology, University of Washington Medicine, Seattle, Washington.
  • Flanagan KC; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • LaFranzo NA; Seattle Cancer Care Alliance, Seattle, Washington.
  • Kim TS; Department of Medical Oncology, University of Washington Medicine, Seattle, Washington.
  • Pollack SM; Sarcoma, Royal Marsden Hospital NHS Trust/Institute of Cancer Research, London, United Kingdom.
Clin Cancer Res ; 28(8): 1701-1711, 2022 04 14.
Article en En | MEDLINE | ID: mdl-35115306

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
...